Skip to main content
. 2017 Dec 5;15(2):1525–1531. doi: 10.3892/etm.2017.5595

Figure 2.

Figure 2.

Levels of c-Jun N-terminal kinase and nuclear factor-κB pathway proteins prior to and after transcatheter closure treatment as well as in the control group. p-IκB, phosphorylated inhibitor of nuclear factor κB. ***P<0.001 vs. the control group; ###P<0.001 vs. the before treatment group.